S&P 500   4,549.34
DOW   36,054.43
QQQ   385.05
14 best consumer staples dividend stocks
Energy Storage Trend Ignites Frenzy Over Vanadium Supply (Ad)
Ex dividend date vs record date: What’s the difference?
How to find blue-chip dividend stocks
Energy Storage Trend Ignites Frenzy Over Vanadium Supply (Ad)
What is the consumer staples sector?
6 best online and direct marketing retail stocks to invest in
Energy Storage Trend Ignites Frenzy Over Vanadium Supply (Ad)
What does consumer price index measure?
Last chance to set up your portfolio for OPEC cuts
S&P 500   4,549.34
DOW   36,054.43
QQQ   385.05
14 best consumer staples dividend stocks
Energy Storage Trend Ignites Frenzy Over Vanadium Supply (Ad)
Ex dividend date vs record date: What’s the difference?
How to find blue-chip dividend stocks
Energy Storage Trend Ignites Frenzy Over Vanadium Supply (Ad)
What is the consumer staples sector?
6 best online and direct marketing retail stocks to invest in
Energy Storage Trend Ignites Frenzy Over Vanadium Supply (Ad)
What does consumer price index measure?
Last chance to set up your portfolio for OPEC cuts
S&P 500   4,549.34
DOW   36,054.43
QQQ   385.05
14 best consumer staples dividend stocks
Energy Storage Trend Ignites Frenzy Over Vanadium Supply (Ad)
Ex dividend date vs record date: What’s the difference?
How to find blue-chip dividend stocks
Energy Storage Trend Ignites Frenzy Over Vanadium Supply (Ad)
What is the consumer staples sector?
6 best online and direct marketing retail stocks to invest in
Energy Storage Trend Ignites Frenzy Over Vanadium Supply (Ad)
What does consumer price index measure?
Last chance to set up your portfolio for OPEC cuts
S&P 500   4,549.34
DOW   36,054.43
QQQ   385.05
14 best consumer staples dividend stocks
Energy Storage Trend Ignites Frenzy Over Vanadium Supply (Ad)
Ex dividend date vs record date: What’s the difference?
How to find blue-chip dividend stocks
Energy Storage Trend Ignites Frenzy Over Vanadium Supply (Ad)
What is the consumer staples sector?
6 best online and direct marketing retail stocks to invest in
Energy Storage Trend Ignites Frenzy Over Vanadium Supply (Ad)
What does consumer price index measure?
Last chance to set up your portfolio for OPEC cuts

Elanco Animal Health Stock Price, News & Analysis (NYSE:ELAN)

$12.87
+0.01 (+0.08%)
(As of 12/6/2023 ET)
Compare
Today's Range
$12.84
$13.21
50-Day Range
$8.59
$12.87
52-Week Range
$7.88
$14.69
Volume
4.88 million shs
Average Volume
6.61 million shs
Market Capitalization
$6.34 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$12.70

Elanco Animal Health MarketRank™ Stock Analysis

Analyst Rating
Hold
2.00 Rating Score
Upside/​Downside
1.3% Downside
$12.70 Price Target
Short Interest
Healthy
2.96% of Shares Sold Short
Dividend Strength
N/A
Sustainability
-4.69
Upright™ Environmental Score
News Sentiment
1.65mentions of Elanco Animal Health in the last 14 days
Based on 3 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
-3.26%
From $0.92 to $0.89 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.29 out of 5 stars

Medical Sector

914th out of 957 stocks

Drug Manufacturers - Specialty & Generic Industry

11th out of 11 stocks


ELAN stock logo

About Elanco Animal Health Stock (NYSE:ELAN)

Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet health therapeutics for pain, osteoarthritis, ear infections, cardiovascular, and dermatology indications in canines and felines under the Galliprant and Claro brands; vaccines, antibiotics, parasiticides, and other products for use in poultry and aquaculture production, as well as nutritional health products, including enzymes, probiotics, and prebiotics; and a range of vaccines, antibiotics, implants, parasiticides, and other products used in ruminant and swine production under the Rumensin and Baytril brands. The company sells its products to third-party distributors; veterinarians; and farm animal producers, including beef and dairy farmers, as well as pork, poultry, and aquaculture operations. The company was founded in 1954 and is headquartered in Greenfield, Indiana.

ELAN Stock Price History

ELAN Stock News Headlines

Americans Now Favor Gold Over Stocks as an Investment Vehicle
Americans now consider gold a better long-term investment than stocks for the first time since 2013. But physical gold requires storage and insurance, and gold mining stocks come with significant risks. Fortunately, investors have found a little-known way to benefit from gold that avoids many of these challenges.
Q3 2023 Elanco Animal Health Inc Earnings Call
Elanco Shares Rise 15% on Raised FY23 Outlook
New CBOE “special perk” helps traders target income every weekend
You might not immediately realize what you’re reading. Let me help you out a little… What you're looking at is a “special perk” set up by the Chicago Board of Options Exchange.
Elanco Raises Adjusted Earnings View on Strong Sales
Elanco Posts Wider Loss on Goodwill Charge
Elanco Animal Health Reports Third Quarter 2023 Results
See More Headlines
Receive ELAN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Elanco Animal Health and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
11/07/2023
Today
12/06/2023
Fiscal Year End
12/31/2023
Next Earnings (Estimated)
2/20/2024

Industry, Sector and Symbol

Industry
Drug Manufacturers - Specialty & Generic
Sub-Industry
N/A
Sector
Medical
Fax
N/A
Employees
9,000
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$12.70
High Stock Price Target
$16.00
Low Stock Price Target
$9.50
Potential Upside/Downside
-1.3%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
5 Analysts

Profitability

Net Income
$-78,000,000.00
Pretax Margin
-26.48%

Debt

Sales & Book Value

Annual Sales
$4.42 billion
Cash Flow
$2.69 per share
Book Value
$15.37 per share

Miscellaneous

Free Float
489,644,000
Market Cap
$6.34 billion
Optionable
Optionable
Beta
1.14
10 Best Stocks to Own in 2024 Cover

Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2024 and why they should be in your portfolio.

Get This Free Report

Key Executives















ELAN Stock Analysis - Frequently Asked Questions

Should I buy or sell Elanco Animal Health stock right now?

5 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Elanco Animal Health in the last twelve months. There are currently 1 sell rating, 3 hold ratings and 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" ELAN shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in ELAN, but not buy additional shares or sell existing shares.
View ELAN analyst ratings
or view top-rated stocks.

What is Elanco Animal Health's stock price target for 2024?

5 analysts have issued 12 month price targets for Elanco Animal Health's stock. Their ELAN share price targets range from $9.50 to $16.00. On average, they anticipate the company's share price to reach $12.70 in the next year. This suggests that the stock has a possible downside of 1.3%.
View analysts price targets for ELAN
or view top-rated stocks among Wall Street analysts.

How have ELAN shares performed in 2023?

Elanco Animal Health's stock was trading at $12.22 on January 1st, 2023. Since then, ELAN stock has increased by 5.3% and is now trading at $12.87.
View the best growth stocks for 2023 here
.

Are investors shorting Elanco Animal Health?

Elanco Animal Health saw a increase in short interest during the month of October. As of October 31st, there was short interest totaling 12,050,000 shares, an increase of 10.2% from the October 15th total of 10,930,000 shares. Based on an average daily volume of 5,170,000 shares, the days-to-cover ratio is presently 2.3 days.
View Elanco Animal Health's Short Interest
.

When is Elanco Animal Health's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, February 20th 2024.
View our ELAN earnings forecast
.

How were Elanco Animal Health's earnings last quarter?

Elanco Animal Health Incorporated (NYSE:ELAN) issued its quarterly earnings data on Tuesday, November, 7th. The company reported $0.18 EPS for the quarter, beating the consensus estimate of $0.12 by $0.06. The firm earned $1.07 billion during the quarter, compared to analysts' expectations of $1.04 billion. Elanco Animal Health had a positive trailing twelve-month return on equity of 6.99% and a negative net margin of 26.18%. The company's revenue for the quarter was up 3.9% compared to the same quarter last year. During the same period in the previous year, the firm earned $0.20 EPS.

What guidance has Elanco Animal Health issued on next quarter's earnings?

Elanco Animal Health updated its FY 2023 earnings guidance on Tuesday, November, 7th. The company provided earnings per share guidance of $0.88-$0.94 for the period, compared to the consensus earnings per share estimate of $0.85. The company issued revenue guidance of $4.36 billion-$4.40 billion, compared to the consensus revenue estimate of $4.37 billion.

What is Jeff Simmons' approval rating as Elanco Animal Health's CEO?

169 employees have rated Elanco Animal Health Chief Executive Officer Jeff Simmons on Glassdoor.com. Jeff Simmons has an approval rating of 89% among the company's employees.

What other stocks do shareholders of Elanco Animal Health own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Elanco Animal Health investors own include NVIDIA (NVDA), AbbVie (ABBV), Micron Technology (MU), QUALCOMM (QCOM), Walt Disney (DIS), Johnson & Johnson (JNJ), AT&T (T), Cisco Systems (CSCO), CVS Health (CVS) and Bristol-Myers Squibb (BMY).

When did Elanco Animal Health IPO?

(ELAN) raised $1.4 billion in an initial public offering (IPO) on Thursday, September 20th 2018. The company issued 62,900,000 shares at $20.00-$23.00 per share. Goldman Sachs, J.P. Morgan and Morgan Stanley served as the underwriters for the IPO and Barclays, BNP PARIBAS, BofA Merrill Lynch, Citigroup, Credit Suisse, Deutsche Bank Securities, Evercore ISI, Cowen, Academy Securities, Drexel Hamilton, Mischler Financial Group, Ramirez and The Williams Capital Group were co-managers.

Who are Elanco Animal Health's major shareholders?

Elanco Animal Health's stock is owned by a variety of institutional and retail investors. Top institutional investors include Primecap Management Co. CA (9.98%), Shapiro Capital Management LLC (3.21%), Black Creek Investment Management Inc. (3.15%), Wellington Management Group LLP (1.26%), Rokos Capital Management LLP (1.08%) and JPMorgan Chase & Co. (1.07%). Insiders that own company stock include Art A Garcia, Elanco Animal Health Inc, Jeffrey N Simmons, John P Bilbrey, Michael J Harrington, R David Hoover and Rajeev A Modi.
View institutional ownership trends
.

How do I buy shares of Elanco Animal Health?

Shares of ELAN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

This page (NYSE:ELAN) was last updated on 12/7/2023 by MarketBeat.com Staff

My Account -